67 (PB057) - Phase I/II trial of RVU120, a CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors.

Authors :: Dziadziuszko, R.
Garralda Cabanas, E.
Rojas, K.
Chelstowska, M.
Blaszkowska, M.
Dudziak, R.
Rzymski, T.
Angelosanto, N.
Littlewood, P.
Nogai, H.
Boni, V.
Lugowska, I.
Source :: European Journal of Cancer. 2022 Supplement 1, Vol. 174, pS23-S23. 1p.
Publication Year :: 2022

Subjects :: *THERAPEUTIC use of antineoplastic agents
*PROTEIN kinase inhibitors
*METASTASIS
*CONFERENCES & conventions
*TUMORS

Full Text Access

Tools